OMNIGENETICA
Platform Solutions Evidence Company

Solutions · 02

Specialty-level panels for the clinics that need them.

Oncology, cardiology, neurology, and rare disease centers map polymorphic risk and pharmacogenomic profiles against deep phenotypic data.

Specialty-level panels with deep phenotypic integration.

01

Oncology

Polygenic risk scores for the most prevalent cancers, hereditary cancer carrier panels, and pharmacogenomic profiles relevant to oncology pharmacotherapy.

02

Cardiology

Cardiovascular polygenic risk modeling including coronary artery disease, atrial fibrillation, and heart failure cohorts, with antithrombotic-relevant PGx.

03

Neurology

Neurodegenerative risk modeling (Alzheimer’s, Parkinson’s) and pharmacogenomic decision-support across neuropsychiatric therapies.

04

Rare disease centers

Carrier status reports covering 40+ inherited conditions, supported by clinical-grade short-read sequencing and rigorous variant annotation.

05

Pharmacogenomics across specialties

100+ medications across 15+ drug classes, with actionable dosing and alternative-medication guidance at the point of care.

06

Rapid clinical reporting

Reports structured for clinician review with prioritized findings, evidence linkage, and patient-facing translation material.

Specialty deployment specs.

Capability
Specification
Hereditary carrier conditions covered
40+
Carrier panel
Pharmacogenomic medications
100+
PGx catalog
Pharmacogenomic drug classes
15+
PGx catalog
Longevity / preventive conditions
30
Longevity Screener
Lifestyle-risk conditions modeled
70+
Lifestyle Risk Analyzer
Lab markers cross-referenced
4,000+
Lab Analyzer